Showing posts with label Steps. Show all posts
Showing posts with label Steps. Show all posts

Wednesday, December 8, 2010

Four steps to reduce diabetes risk

Current rates show that about one in 10 have diabetes, but that's expected to rise to one in three Americans by 2050.Current rates show that about one in 10 have diabetes, but that's expected to rise to one in three Americans by 2050.Despite such gloomy projections, diabetes is not inevitableGenetics, race and family history affect a person's chances of developing diabetesProper diet, exercise, finding support group can help reduce risk

(CNN) -- Half of all Americans may be diabetic or prediabetic by 2020, a report from an insurance company warned Tuesday. That's an even bleaker projection than the Centers for Disease Control's recent estimate that one in three Americans would have diabetes by 2050.

Current rates show that about one in 10 Americans has diabetes, and the risks increase with age. Even children and teenagers are developing type 2 diabetes.

A report released this week by UnitedHealth Group showed that treating diabetes will also take up almost 10 percent of all health care spending. That 10-year price tag: $3.35 trillion.

Despite such gloomy projections, diabetes is not inevitable. Practical health changes can lower risk of type 2 diabetes, which occurs more commonly with aging and sedentary lifestyles. Type 1 diabetes is an autoimmune disease unrelated to aging or lifestyle.

While diabetes projections sound scary, "the numbers are getting people aware about the risk factors and thinking about them," said Beth Mayer-Davis, the president-elect of health care and education at the American Diabetes Association.

4 keys to managing diabetes: How do you rate?

Genetics, race and family history affect a person's chances of developing diabetes, but you can take steps to lower your risk of type 2 diabetes.

The most important thing: Lose weight

"The heavier we are, the tougher it is for our body," said Dr. Armand Krikorian, who specializes in endocrinology and diabetes at University Hospitals Case Medical Center in Ohio. "It has to make more insulin to keep the blood sugar under control."

Insulin, a substance created in the pancreas, moves glucose from the bloodstream into muscles, fat and liver cells. But in type 2 diabetes, the body doesn't respond to insulin, and glucose builds up in the blood.

Overweight people are more likely to develop diabetes because the fat interferes with the body's ability to use insulin.

Krikorian used this analogy: "You have a horse; you're asking it to run all the time. You're whipping it to run faster all the time, and it can't do it any more. The heavier I am, the more I'm asking my pancreas to make more insulin to keep sugars under control. Over the long term, it's exhausting the pancreas, and that's when diabetes sets in."

About half of overweight or obese people have prediabetes or diabetes, said Mayer-Davis, a epidemiologist specializing in diabetes.

Exercise burns energy and helps the body manage the glucose.

"It doesn't have to be running a marathon," Krikorian said. "Any amount of regular scheduled activity, the more, the better. A half an hour of daily activity is a good start."

Studies have found that 7 to 10 percent body weight loss can greatly help with diabetes prevention.

"We're not saying you have to become fashion magazine models," Mayer-Davis said. "If you're 300 pounds, a 10 percent weight loss, that's 30 pounds."

Watch your food's quality and quantity

It's the mantra of public health: Eat your fruits and veggies.

Toby Smithson, a registered dietitian and a spokeswoman for the American Dietetic Association, also suggests eating nutrient-dense foods such as lean protein, whole grains and low-fat dairy.

"All foods can fit into a healthy diet," she said. "The key is the portion and to make sure it is balanced throughout the day."

Although everyone has different dietary needs, a general guideline is two servings of low-fat or non-fat milk or yogurt, two to five servings of fruit; four to 12 servings of grains, beans or starchy vegetables; three to five servings of non-starchy vegetables; and two to three servings of lean protein (5 to 9 ounces) each day.

Studies show that a diet with lower fat reduces diabetes risk. But it doesn't matter which weight-loss plan a person chooses, as long as it reduces calories, Mayer-Davis said.

Find support

People know that they should eat right and exercise but struggle to execute.

Studies show that people in a group lifestyle intervention could reduce their diabetes risks. One of the best-known programs came from the CDC, the YMCA and United Health Group. The Diabetes Prevention Program assigns a lifestyle coach to participants who are at high risk of developing diabetes. The group learns about ways to eat healthier, exercise and make lifestyle improvements. They meet monthly.

"The group dynamic can share the things that worked for them, their successes and struggles, that can be helpful to people," Mayer-Davis said.

If support groups aren't available, find supportive friends, partners or people who will encourage you, she said.

Act now, before you're diabetic

"If you don't want to have diabetes and end up monitoring blood sugar, taking pills and insulin, this is the time to act," Krikorian said. "Stay active, lose weight and prevent getting the diabetes. It is preventable."

In general, about a third of the people who are in the category of prediabetes develop diabetes after three to five years.

"Having prediabetes doesn't mean you're going to have diabetes," Krikorian said. "Unfortunately, a lot of time, we don't act till it's too late. We procrastinate. When we don't feel imminent danger, we tend to be lax."

Prediabetes means you've tested higher than the normal levels on one of the three tests: A1C, fasting plasma glucose or oral glucose tolerance.

That means levels above 5.7 percent on an A1C test, 100 milligrams per deciliter on the fasting plasma glucose test and 140 milligrams per deciliter on the oral glucose tolerance test. The American Diabetes Association has more on prediabetes.

Diabetes can be controlled

Diabetes doesn't necessarily mean amputations, blindness or dialysis. Those are worst-case complications.

Many people control their diabetes through proper diet and exercise, and thrive without medication.

Although they're not "cured," they're able to control the disease.

"The positive message is that the complications are preventable," Krikorian said. "It doesn't mean they're doomed."


View the original article here

Sunday, December 5, 2010

Are Your Legs Telling You Something? People With Diabetes Urged To Take Steps To Learn About P.A.D.


Main Category: Diabetes
Also Included In: Vascular
Article Date: 22 Nov 2010 - 2:00 PST window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend ? printer icon printer friendly ? write icon opinions ?
4 stars5 stars
P.A.D. occurs when arteries in the legs become narrowed or clogged with fatty deposits, reducing blood flow to the legs. This can result in leg muscle pain when walking, disability, amputation, and poor quality of life. Blocked arteries found in people with P.A.D. can be a red flag that other arteries, including those in the heart and brain, may also be blocked - increasing the risk of a heart attack or stroke.

November is National Diabetes Month, and the Vascular Disease Foundation and its P.A.D. Coalition are urging people with diabetes to be alert to the warning signs of P.A.D. People with P.A.D. may have one or more of the following symptoms:

- "Claudication" - fatigue, heaviness, tiredness or cramping in the leg muscles (calf, thigh or buttocks) that occurs during activity such as walking and goes away with rest.

- Foot or toe pain at rest that often disturbs sleep

- Skin wounds or ulcers on the feet or toes that are slow to heal (or that do not heal for 8 to 12 weeks).

Unfortunately, P.A.D. is often a silent disease, causing no recognizable symptoms. National medical guidelines recommend that adults over 50 years of age with diabetes be tested for P.A.D. Testing should also be considered in patients under 50 years of age with diabetes and at least one other cardiovascular risk factors such as a history of smoking, abnormal cholesterol and/or high blood pressure. The test for P.A.D. is called the ankle-brachial index, a painless, non-invasive test that compares the blood pressure in the ankles with the blood pressure in the arms.

"Poor circulation in the legs - particularly in people with diabetes - is a serious problem," stated Joseph Caporusso, DPM, Chair of the P.A.D. Coalition. "Without proper blood flow, a minor problem such as a cut or blister may not heal properly and may lead to an infection. If not treated promptly, these problems can result in amputation of a toe, foot or part of the leg."

Source:
Vascular Disease Foundation
P.A.D. Coalition

Please rate this article:
(Hover over the stars
then click to rate) Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

All opinions are moderated before being added.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:






View the original article here

Monday, November 22, 2010

Press Release - JDRF Clinical Panel Recommends Next Steps for Artificial Pancreas Clinical Testing

This press release is an announcement submitted by JDRF, and was not written by Diabetes Health.

WASHINGTON, D.C., Nov. 10, 2010 --- Diabetes experts at a meeting convened by the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) took the next step in advancing efforts toward the development of an artificial pancreas: putting forth clinical recommendations to ensure the safe and effective testing of artificial pancreas technology in real-life situations. We are pleased at today's meeting there was a strong consensus among leading clinicians, researchers and industry leaders regarding the path toward outpatient studies for both low-glucose suspend and artificial pancreas systems.?

Even with treatments available today, tight blood sugar control remains a challenge and daily struggle for those living with type 1 diabetes. In fact, the majority of people living with the disease are not achieving recommended target levels. "An artificial pancreas, essentially a device that would both measure blood sugar and dispense appropriate amounts of insulin to keep levels in optimal range, would take much of the guesswork out of daily management of the disease," said Dr. Aaron Kowalski, Assistant Vice President of Treatment Therapies at JDRF. "In the long-run, controlled blood sugar levels will help to lessen or avert the devastating complications from type 1 diabetes."

To date, artificial pancreas devices have been successfully tested in controlled inpatient or hospital settings, demonstrating the potential for this technology to improve blood sugar control. Now it must be tested safely in real-world conditions. And clear and reasonable regulatory guidelines must be established to ensure that the upcoming studies advance the technology to reach patients as soon as possible.

"We believe a safe and effective first generation artificial pancreas system is possible with today's technology, even as we continue to encourage development of improved devices. Experts at today's FDA workshop outlined a clear path forward to safely speed the development and delivery of artificial pancreas systems to patients," said Jeffrey Brewer, President and CEO of JDRF.

To help advance these efforts, JDRF formed a Clinical Panel of internationally renowned leaders in the diabetes field to make recommendations to FDA on key clinical steps and issues critical to the advancement of studies of these systems outside of the hospital. Panel members speaking at today's workshop included David Nathan, Director, Clinical Research Center and Diabetes Center at Massachusetts General Hospital and Professor of Medicine, Harvard Medical School; and William Tamborlane,?Professor and Chief of Pediatric Endocrinology and Diabetes, Yale University School of Medicine.?

The panel developed a series of clinical recommendations that were shared at today's meeting. They were based on key areas addressed by the FDA, NIH, JDRF, clinicians and industry.? First, the recommendations addressed questions on how should studies on artificial pancreas systems move safely from inpatient (hospital) settings to outpatient (real-world) testing. Second, the panel identified which subset of patients should be considered when testing artificial pancreas systems. The third area focused on how to ensure the safety of patients participating in the studies and eventually for everyday use.? Lastly, the panel identified what outcomes should be measured in studies to demonstrate the safety and effectiveness of the device.

A summary of the panel's recommendations is available?here.? A full report by the panel will be forthcoming.

According to panel chair Robert Sherwin, M.D., Yale University, "The panel believes, with certain safeguards, artificial pancreas systems can be safely tested in real world settings."

"The incidence of type 1 diabetes is on the rise. Today's tools to manage the disease are insufficient. We have the technology at our disposal to make an artificial pancreas work. Now it's time to move forward quickly to define the regulatory pathway so final studies can be completed and better technologies can be made available to adults and children struggling with this difficult disease," added Mr. Brewer.

About JDRF's Artificial Pancreas Project

JDRF launched the Artificial Pancreas Project in 2005?to speed the development of automated diabetes management systems.?? A self-regulating system, the artificial pancreas would be able to sense sugar levels continuously and automatically release the right amount of insulin at the right times - eliminating the need for multiple blood tests, insulin injections and therefore lifting the daily burden associated with managing diabetes.

Since that time, JDRF has supported a number of initiatives that have advanced progress toward the development of an artificial pancreas. This has included the formation of the Artificial Pancreas Consortium, a group of university-based mathematicians, engineers, and diabetes experts to develop the computer algorithms that are needed to connect the devices needed to form a closed-loop system.

In addition to the consortium, JDRF has collaborated with several industry partners to develop a first-generation artificial pancreas system, as well as better and faster-acting insulin products, a key component of developing a safe and effective artificial pancreas system.

More information about JDRF's Artificial Pancreas Project can be found online at?www.jdrf.org/artificialpancreasproject.? The site includes information for people with type 1 diabetes about research leading to the development of an artificial pancreas, as well as interactive tools, project timelines, chats with researchers, and access to information about clinical trials.

JDRF is the leader in research leading to a cure for type 1 diabetes in the world.? It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide.

The mission of JDRF is to find a cure for diabetes and its complications through the support of research.? Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal.? Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump - each day, every day of their lives.? And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.

Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $1.5 billion to diabetes research, including more than $107 million last year. More than 80 percent of JDRF's expenditures directly support research and research-related education.? For more information, please visit?www.jdrf.org.


View the original article here

Wednesday, November 17, 2010

JDRF Clinical Panel Recommends Next Steps For Artificial Pancreas Clinical Testing


Main Category: Diabetes
Also Included In: Medical Devices / Diagnostics;??IT / Internet / E-mail;??Regulatory Affairs / Drug Approvals
Article Date: 11 Nov 2010 - 4:00 PST window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend ? printer icon printer friendly ? write icon opinions ?
not yet ratednot yet rated
Diabetes experts at a meeting convened by the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) took the next step in advancing efforts toward the development of an artificial pancreas: putting forth clinical recommendations to ensure the safe and effective testing of artificial pancreas technology in real-life situations. We are pleased at today's meeting there was a strong consensus among leading clinicians, researchers and industry leaders regarding the path toward outpatient studies for both low-glucose suspend and artificial pancreas systems.

Even with treatments available today, tight blood sugar control remains a challenge and daily struggle for those living with type 1 diabetes. In fact, the majority of people living with the disease are not achieving recommended target levels. "An artificial pancreas, essentially a device that would both measure blood sugar and dispense appropriate amounts of insulin to keep levels in optimal range, would take much of the guesswork out of daily management of the disease," said Dr. Aaron Kowalski, Assistant Vice President of Treatment Therapies at JDRF. "In the long-run, controlled blood sugar levels will help to lessen or avert the devastating complications from type 1 diabetes."

To date, artificial pancreas devices have been successfully tested in controlled inpatient or hospital settings, demonstrating the potential for this technology to improve blood sugar control. Now it must be tested safely in real-world conditions. And clear and reasonable regulatory guidelines must be established to ensure that the upcoming studies advance the technology to reach patients as soon as possible.

"We believe a safe and effective first generation artificial pancreas system is possible with today's technology, even as we continue to encourage development of improved devices. Experts at today's FDA workshop outlined a clear path forward to safely speed the development and delivery of artificial pancreas systems to patients," said Jeffrey Brewer, President and CEO of JDRF.

To help advance these efforts, JDRF formed a Clinical Panel of internationally renowned leaders in the diabetes field to make recommendations to FDA on key clinical steps and issues critical to the advancement of studies of these systems outside of the hospital. Panel members speaking at today's workshop included David Nathan, Director, Clinical Research Center and Diabetes Center at Massachusetts General Hospital and Professor of Medicine, Harvard Medical School; and William Tamborlane, Professor and Chief of Pediatric Endocrinology and Diabetes, Yale University School of Medicine.

The panel developed a series of clinical recommendations that were shared at today's meeting. They were based on key areas addressed by the FDA, NIH, JDRF, clinicians and industry. First, the recommendations addressed questions on how should studies on artificial pancreas systems move safely from inpatient (hospital) settings to outpatient (real-world) testing. Second, the panel identified which subset of patients should be considered when testing artificial pancreas systems. The third area focused on how to ensure the safety of patients participating in the studies and eventually for everyday use. Lastly, the panel identified what outcomes should be measured in studies to demonstrate the safety and effectiveness of the device.

According to panel chair Robert Sherwin, M.D., Yale University, "The panel believes, with certain safeguards, artificial pancreas systems can be safely tested in real world settings."

"The incidence of type 1 diabetes is on the rise. Today's tools to manage the disease are insufficient. We have the technology at our disposal to make an artificial pancreas work. Now it's time to move forward quickly to define the regulatory pathway so final studies can be completed and better technologies can be made available to adults and children struggling with this difficult disease," added Mr. Brewer.

About JDRF's Artificial Pancreas Project

JDRF launched the Artificial Pancreas Project in 2005 to speed the development of automated diabetes management systems. A self-regulating system, the artificial pancreas would be able to sense sugar levels continuously and automatically release the right amount of insulin at the right times eliminating the need for multiple blood tests, insulin injections and therefore lifting the daily burden associated with managing diabetes.

Since that time, JDRF has supported a number of initiatives that have advanced progress toward the development of an artificial pancreas. This has included the formation of the Artificial Pancreas Consortium, a group of university-based mathematicians, engineers, and diabetes experts to develop the computer algorithms that are needed to connect the devices needed to form a closed-loop system.

In addition to the consortium, JDRF has collaborated with several industry partners to develop a first-generation artificial pancreas system, as well as better and faster-acting insulin products, a key component of developing a safe and effective artificial pancreas system.

Source: Juvenile Diabetes Research Foundation

Please rate this article:
(Hover over the stars
then click to rate) Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

All opinions are moderated before being added.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:






View the original article here

Friday, November 12, 2010

Diabetes: 5 Steps to Total Body Care

If you have type 2 diabetes, you know that blood sugar control, a balanced diet, weight management, regular exercise, and checkups are vital to your health. Taking special care of every part of your body to avoid serious complications is just as critical.

Among some of your biggest concerns with diabetes care are:

Foot infectionsChronic skin infectionsGum disease and tooth lossVision problemsHeart disease and blood circulation problems

The need to take care of yourself isn't just for adults; with the epidemic of childhood obesity, type 2 diabetes has also become more prevalent among children, teens, and young adults.

"In hospitals, we're seeing first-time patients in their late 20s and 30s who have uncontrolled blood sugar and severe skin infections that probably started as a boil or a spider bite," says Philip Orlander, MD, director of endocrinology at The University of Texas Medical School at Houston.

How can diabetes so dramatically damage the body? If blood sugar is uncontrolled, blood vessels and nerves become damaged, while the body becomes less able to fight infections.

Controlling blood sugar is the bottom line in preventing these problems, but personal care routines -- simple things you can do every day -- can dramatically reduce your risks, too.

Your feet, skin, eyes, heart, and teeth and gums need special attention if you have diabetes. Here are steps you can take to care for these parts of your body:

1. Foot Care and Diabetes

Common foot problems can cause many complications, including athlete's foot, fungal infections in nails, calluses, corns, blisters, bunions, dry skin, sores, hammertoes, ingrown toenails, and plantar warts.

While anyone can have these problems, they're more critical for people with diabetes because:

If you have nerve damage, you may not feel small wounds that need treatment.Poor blood flow can slow wound healing.If you're immune suppressed, you may be more prone to infection.Damaged foot muscle nerves may prevent your foot from aligning properly, causing you to put more pressure on one area of the foot, leading to foot sores and pressure point ulcers.

Prevention tips: Make time for foot care daily. Wash, dry and examine the tops and bottoms of your feet. Check for cracked skin, cuts, scratches, wounds, blisters, redness, calluses, and other changes. Use antibiotic creams recommended by your doctor and apply sterile bandages to protect cuts. Prevent ingrown toenails by cutting toenails straight across; don't cut corners. Don't go barefoot and always protect your feet. Make sure you wear properly fitting footwear.

If you develop even minor foot problems, treat them right away or see a doctor. And see a foot doctor (podiatrist) every two or three months.

Checking your feet daily means you can catch small things and get them treated before they become serious. Make it part of your daily morning routine -- it doesn't take long.


View the original article here